Found 544 hits.
| 171 | Reiter, N., Reiter, M., Altrichter, S., Becker, S., Kristensen, T., Broesby-Olsen, S., Church, M. K., Metz, M., Maurer, M. and Siebenhaar, F.+: Anaphylaxis caused by Mosquito allergy in systemic mastocytosis. Lancet 2013: 382; 1380. IF: 39.21 |
| 150 | Maurer, M.+, Hawro, T., Krause, K., Magerl, M., Metz, M., Siebenhaar, F., Terhorst-Molawi, D., Weller, K., Zuberbier, T., and Altrichter, S.: Diagnosis and treatment of chronic inducible urticaria. Allergy 2019: 74; 2550-2553. IF: 8.71 |
r.150
|
563. |
Pyatilova, P., Bernstein, J. A., Aulenbacher, F., Sanchez Borges, M., Dimitrijević, S., Hoehn, G., Maurer, M., Kolkhir, P.*, and Siebenhaar, F.*+: The diagnostic workup for systemic mastocytosis differs from consensus recommendations: results of a worldwide survey. World Allergy Organ J. 2023: 16; 100838. IF: 3.90 |
o.563
| 69 | Magerl, M., Schmolke, J., Metz, M., Zuberbier, T., Siebenhaar, F., and Maurer, M.+: Prevention of signs and symptoms of dermographic urticaria by single-dose ebastine 20 mg. Clin. Exp. Dermatol. 2009: 34; e137-e140. IF: 1.55 |
|
497. |
Buttgereit, T., Gu, S., Carneiro-Leão, L., Gutsche, A., Maurer, M.+, and Siebenhaar, F.: Idiopathic mast cell activation syndrome is more often suspected than diagnosed – a prospective real-life study. Allergy 2022: 77; 2794-2802. IF: 12.40 |
o.497
| 83 | Schulz, S., Metz, M., Siepmann, D., Luger, T. A., Maurer, M. and Ständer, S.+: Antipruritic efficacy of a high-dosage antihistamine therapy: Results of a retrospectively analysed case series. Hautarzt 2009: 60; 564-568. IF: 0.43 |
| 193 | Siebenhaar, F.+, Metz, M., and Maurer, M.: Mast cells protect from skin tumor development and limit tumor growth during cutaneous de novo carcinogenesis in a Kit-dependent mouse model. Exp. Dermatol. 2014: 23; 159-164. IF: 3.76 |
|
210. |
Metz, M., Kolkhir, P., Altrichter, S., Siebenhaar, F., Levi-Schaffer, F., Youngblood, B. A., Church, M. K., and Maurer, M.+: Mast cell silencing: a novel therapeutic approach for urticaria and other mast cell-mediated diseases. Allergy 2023: 79; 37-51. IF: 12.60 |
r.210
|
507. |
Pyatilova, P., Ashry, T., Luo, Y., He, J., Bonnekoh, H., Jiao, Q., Moñino-Romero, S., Hu, M., Scheffel, J., Frischbutter, S., Hermans, M. A. W., Youngblood, B. A., Maurer, M., Siebenhaar, F.*, and Kolkhir, P.+*: The number of MRGPRX2-expressing cells is increased in skin lesions of patients with indolent systemic mastocytosis, but is not linked to symptom severity. Front. Immunol. 2022: 13; 930945. IF: 7.30 |
o.507
| 202 | Schmetzer, O.+, Valentin, P., Smorodchenko, A., Domenis, R., Gri, G., Siebenhaar, F., Metz, M., and Maurer, M.: A novel method to generate and culture human mast cells: Peripheral CD34+ stem cell-derived mast cells (PSCMCs). J. Immunol. Methods 2014: 413; 62-68. IF: 2014: 1.82 |